PTIE

Pain Therapeutics Reports Q3 2012 Financial Results

[at noodls] – On Track With Financial Guidance for 2012 AUSTIN, Texas, Nov. 8, 2012 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the quarter and nine months ended September … moreView todays social media effects on PTIEView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: Pfizer Spooks Durect Investors, Creates Opportunity

[ACN Newswire] – By Jason Napodano, CFAOn November 1, 2012, Pfizer (NYSE:PFE) held a conference call ( webcast link ) to discuss its third quarter earnings and financial outlook with investors. In the past, Pfizer’s conference … moreView todays social media effects on PTIEView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: PTIE Down on Disappointing Pfizer Commentary and Pushback; Stock Could Trade Lower

[ACN Newswire] – By David MoskowitzShares of Pain Therapeutics (NASDAQ:PTIE) are off 25% as partner Pfizer (NYSE:PFE) noted Thursday on its earnings call that Remoxy, PTIE’s lead product, is a challenging asset … moreView todays social media effects on PTIEView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: Peregrine Shares Continue to Bleed, Sticking Around Could Hurt Worse

[ACN Newswire] – By David MoskowitzPeregrine Pharmaceuticals (NASDAQ:PPHM) opened down in early trading, as investors are still getting over the shock of the favorable clinical trial results for bavituximab reported last … moreView todays social media effects on PTIEView the latest stocks trending across Twitter. Click to view dashboard […]